Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Drivxoib 90mg Tablet

Prescription Icon
Prescription Required

Marketer

Addii Biotech Pvt Ltd

Salt Composition

Etoricoxib (90mg)

Overview Drivxoib 90mg Tablet

Arthalox 90mg tablets offer effective pain relief. This medication targets moderate joint pain and inflammation associated with various arthritic and gout conditions, significantly reducing pain, redness, and swelling. Arthalox 90mg can be administered with or without food; dosage is determined by your physician based on your specific needs and response to treatment. Strictly adhere to your doctor's prescribed regimen; avoid exceeding the recommended dose or duration. Common side effects may include abdominal discomfort, swelling, lightheadedness, cephalalgia, cardiac arrhythmia, and elevated blood pressure. While generally mild, consult your doctor if these concerns persist. Prior to commencing treatment, inform your physician of any pre-existing conditions, including gastric ulcers or bleeding, hypertension, or cardiovascular, renal, or hepatic impairments. Complete disclosure of all current medications is crucial due to potential interactions. Consult your doctor before using Arthalox 90mg if you are pregnant, breastfeeding, or consume alcohol regularly, as excessive alcohol intake may increase drowsiness.

Uses of Drivxoib 90mg Tablet

Analgesia

Major Benefits of Drivxoib 90mg Tablet:

Administer Drivxoib 90mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.

Common Side effects of Drivxoib 90mg Tablet:

  • Palpitations
  • High blood pressure
  • Dizziness
  • Bronchospasm
  • Stomach inflammation
  • Increased liver enzymes
  • Abdominal pain
  • Vomiting
  • Nausea
  • Edema (swelling)
  • Headache
  • Constipation
  • Diarrhea
  • Gastro-esophageal reflux disease
  • Dyspepsia
  • Oral ulcer
  • Increased alanine aminotransferase
  • Increased aspartate aminotransferase
  • Ecchymosis (discoloration of the skin resulting from bleeding underneath)
  • Weakness
  • Flu-like symptoms
  • Flatulence
  • Dry socket

How to use Drivxoib 90mg Tablet:

Consume Drivxoib 90mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, though consistent timing is recommended.

How Drivxoib 90mg Tablet works:

A single 90mg tablet of Drivxoib, a COX-2 inhibitor NSAID, reduces pain and inflammation by selectively inhibiting the production of specific inflammatory mediators.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Drivxoib 90mg Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Drivxoib 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation-related data for Drivxoib 90mg Tablet are absent. Seek medical advice.

DrivingDrivingUNSAFE

Taking a Drivxoib 90mg Tablet might cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving while experiencing these effects.

KidneyKidneyCAUTION

For individuals with kidney impairment, the administration of Drivxoib 90mg tablets requires careful monitoring. Dosage modification of Drivxoib 90mg tablets may be necessary. Physician consultation is advised. Drivxoib 90mg tablets are contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Drivxoib 90mg tablets cautiously, potentially requiring dosage modification under medical supervision. Drivxoib 90mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Drivxoib 90mg Tablet :

Should you forget a Drivxoib 90mg Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Drivxoib 90mg Tablet

LabelValue
Type of Compound Sulfonamides and pyridine-based compounds
Addictive None.
Medication Classification Medication for Pain Relief

FAQs on Drivxoib 90mg Tablet

Rheumacin 90mg tablets alleviate joint and muscle pain and inflammation in patients aged 16 and above diagnosed with rheumatoid arthritis, ankylosing spondylitis, or gout. This medication also provides short-term relief from moderate post-dental surgery pain in individuals 16 years or older.
The 90mg Drivxoib tablet is generally well-tolerated. Nevertheless, some individuals may experience adverse reactions including nausea, vomiting, abdominal discomfort, tiredness, or loose stools. Report any ongoing issues stemming from this drug to your physician.
Continue taking Drivxoib 90mg tablets as directed by your physician for chronic pain management. For short-term pain, the medication may be stopped once the pain subsides.
Drivxoib 90mg Tablets may induce nausea and vomiting. Consuming this medication with milk, food, or antacids can mitigate nausea. Refrain from consuming fatty or fried foods concurrently. Should vomiting occur, replenish fluids by sipping small amounts of water frequently. Consult your physician if vomiting continues and you experience dehydration symptoms such as dark, strong-smelling urine or infrequent urination. Do not use other medications without first consulting your doctor.
Dizziness (including faintness, weakness, unsteadiness, or lightheadedness) is a potential side effect of Drivxoib 90mg Tablet in some individuals. Should dizziness occur, avoid operating machinery or driving. Rest is recommended until symptoms subside.
Drivxoib 90mg Tablets are contraindicated in individuals with hypersensitivity to any constituent. Patients with known allergies to other nonsteroidal anti-inflammatory drugs (NSAIDs) should also avoid this medication. Its use is inadvisable for those with a history of peptic ulcers or active/recurrent stomach ulceration or bleeding. Furthermore, patients with a history of congestive heart failure, hypertension, or hepatic or renal impairment should not take Drivxoib 90mg Tablets.
Stomach pain should not prompt self-administration of Drivxoib 90mg tablets without prior medical consultation. This medication elevates stomach acid production, potentially worsening undiagnosed medical issues.
Chronic administration of Drivxoib 90mg Tablet can indeed compromise renal function. Prostaglandins, crucial kidney-protective chemicals naturally produced by healthy kidneys, are depleted by analgesic use. This prostaglandin reduction, resulting from prolonged painkiller consumption, increases the risk of kidney damage. Consequently, patients with pre-existing kidney conditions should avoid taking such medications.
Exceeding the prescribed dosage of Drivxoib 90mg Tablets elevates the likelihood of adverse reactions such as abdominal discomfort, nausea, emesis, dyspepsia, and bowel looseness. Prolonged use of this medication may also impair kidney function. Should pain intensify or fail to respond to the recommended dose, seek medical advice for reassessment.
Affirmative. Drivxoib 90mg tablets may elevate blood pressure in certain individuals, particularly with higher dosages. Your physician might recommend regular home blood pressure monitoring. Prior to commencing Drivxoib 90mg tablet therapy, individuals with uncontrolled hypertension should disclose this condition to their doctor to prevent complications.
Continue using Drivxoib 90mg Tablets according to your physician's instructions. While typically prescribed for three days to manage dental pain, treatment of acute pain should continue only as long as the pain persists, up to a maximum of eight days. In cases of arthritis, the prescribed duration will be determined individually and may be long-term.
Administer Drivxoib 90mg tablets precisely as directed by your physician. Ingest the tablet whole with water. Consumption may occur with or without food; however, taking it on an empty stomach may improve its efficacy. Do not surpass the prescribed dosage.
Drivxoib 90mg tablets may induce drowsiness, vertigo, and dizziness in certain individuals. Patients experiencing these effects should refrain from driving or operating equipment.
Concurrent use of Drivxoib 90mg tablets with oral contraceptives or hormone replacement therapy might heighten the risk of adverse reactions. Therefore, a physician should be consulted to explore alternative contraceptive options.
Low-dose aspirin is sometimes prescribed for stroke and heart attack prevention. Discontinuing low-dose aspirin should only occur after consulting your physician. Concurrent use of Drivxoib 90mg Tablet and high-dose aspirin or other anti-inflammatory drugs is discouraged due to an elevated risk of stomach ulcers.
Analgesia typically begins approximately four hours post-administration of a 90mg Drivxoib tablet. Complete efficacy may require additional time and is subject to individual variability.
Drivxoib 90mg tablets provide pain relief. This medication reduces pain and inflammation affecting joints and muscles, offering relief from osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. It also alleviates post-surgical dental pain.
Patients exhibiting compromised renal function, advanced heart failure, or significant hepatic impairment (cirrhosis) should exercise caution when using Drivxoib 90mg tablets, as the medication may exacerbate these conditions. Infrequent adverse renal effects associated with Drivxoib 90mg tablets include proteinuria, elevated serum creatinine levels, and acute kidney injury.
Continue using Drivxoib 90mg Tablets for the duration advised by your physician. Dental pain treatment typically lasts three days, while acute pain management necessitates usage until pain subsides, never exceeding eight days. Arthritis treatment with this medication often involves long-term use, with individual durations varying.
Administer the 90mg Drivxoib tablet precisely as directed by your physician. Ingest the tablet whole with water. The 90mg Drivxoib tablet may be consumed with or without food; however, taking it on an empty stomach may improve its efficacy. Do not surpass the prescribed dosage.
Drivxoib 90mg tablets may induce drowsiness, vertigo, and dizziness in certain individuals. Patients experiencing these side effects should refrain from driving or operating equipment.
Concurrent use of Drivxoib 90mg tablets with oral contraceptives or hormone replacement therapy might heighten the risk of adverse reactions. Therefore, a physician should be consulted to explore alternative contraceptive options.
Low-dose aspirin is used to help prevent strokes and heart attacks. Discontinuing low-dose aspirin should only occur after consulting your physician. Concurrent use of Drivxoib 90mg Tablet and high-dose aspirin or other anti-inflammatory drugs is discouraged due to an elevated risk of stomach ulcers.
Analgesia typically begins approximately four hours post-administration of a 90mg Drivxoib tablet. Complete efficacy might require additional time and shows individual variability.
Drivxoib 90mg tablets provide pain relief. This medication reduces pain and inflammation affecting muscles and joints, specifically in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and gout. Post-dental surgery pain is also alleviated by its use.
Patients exhibiting compromised renal function, severe cardiac insufficiency, or advanced hepatic impairment (cirrhosis) should exercise caution when using Drivxoib 90mg Tablet, as it may exacerbate these conditions. Infrequent renal adverse effects associated with Drivxoib 90mg Tablet include proteinuria, elevated serum creatinine, and acute kidney injury.
Drivxoib 90mg Tablet
78
MRP 95
17% off